References
Alarcón, M., Abrahams, B. S., Stone, J. L., Duvall, J. A., Perederiy, J. V., Bomar, J. M., et al. (2008). Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. American Journal of Human Genetics, 82, 150–159. doi:10.1016/j.ajhg.2007.09.005.
Arking, D. E., Cutler, D. J., Brune, C. W., Teslovich, T. M., West, K., Ikeda, M., et al. (2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. American Journal of Human Genetics, 82, 160–164. doi:10.1016/j.ajhg.2007.09.015.
Bakkaloglu, B., O’Roak, B. J., Louvi, A., Gupta, A. R., Abelson, J. F., Morgan, T. M., et al. (2008). Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. American Journal of Human Genetics, 82, 165–173. doi:10.1016/j.ajhg.2007.09.017.
Manev, R., & Manev, H. (2001). Aminoglycoside antibiotics and autism: a speculative hypothesis. BMC Psychiatry, 1, 5.
Stephan, D. A. (2008). Unraveling autism. American Journal of Human Genetics, 82, 7–9. doi:10.1016/j.ajhg.2007.12.003.
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., et al. (2006). Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. The New England Journal of Medicine, 354, 1370–1377. doi:10.1056/NEJMoa052773.
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., et al. (2007). PTC124 targets genetic disorders caused by nonsense mutations. Nature, 447, 87–91.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manev, H., Manev, R. Pharmacological Probing of Type 1 Autism. J Autism Dev Disord 38, 1400–1401 (2008). https://doi.org/10.1007/s10803-008-0594-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-008-0594-2